DK521386A - Fremgangsmaade til bestemmelse af aminosyre-sekvensen af et polypeptid, som er komplementaert til et peptid eller protein eller en del heraf, samt middel til brug ved fremgangsmaaden - Google Patents

Fremgangsmaade til bestemmelse af aminosyre-sekvensen af et polypeptid, som er komplementaert til et peptid eller protein eller en del heraf, samt middel til brug ved fremgangsmaaden

Info

Publication number
DK521386A
DK521386A DK521386A DK521386A DK521386A DK 521386 A DK521386 A DK 521386A DK 521386 A DK521386 A DK 521386A DK 521386 A DK521386 A DK 521386A DK 521386 A DK521386 A DK 521386A
Authority
DK
Denmark
Prior art keywords
procedure
peptide
polypeptyd
complemented
protein
Prior art date
Application number
DK521386A
Other languages
English (en)
Other versions
DK521386D0 (da
Inventor
J Edwin Blalock
Kenneth L Bost
Eric M Smith
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/708,001 external-priority patent/US4863857A/en
Application filed by Univ Texas filed Critical Univ Texas
Publication of DK521386D0 publication Critical patent/DK521386D0/da
Publication of DK521386A publication Critical patent/DK521386A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in epitope analysis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695—Corticotropin [ACTH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/803—Physical recovery methods, e.g. chromatography, grinding

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
DK521386A 1985-03-01 1986-10-31 Fremgangsmaade til bestemmelse af aminosyre-sekvensen af et polypeptid, som er komplementaert til et peptid eller protein eller en del heraf, samt middel til brug ved fremgangsmaaden DK521386A (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/708,001 US4863857A (en) 1985-03-01 1985-03-01 Polypeptide complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known
US06/829,709 US5077195A (en) 1985-03-01 1986-02-19 Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor
PCT/US1986/000353 WO1986005208A1 (en) 1985-03-01 1986-02-24 Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor

Publications (2)

Publication Number Publication Date
DK521386D0 DK521386D0 (da) 1986-10-31
DK521386A true DK521386A (da) 1986-12-29

Family

ID=27108003

Family Applications (1)

Application Number Title Priority Date Filing Date
DK521386A DK521386A (da) 1985-03-01 1986-10-31 Fremgangsmaade til bestemmelse af aminosyre-sekvensen af et polypeptid, som er komplementaert til et peptid eller protein eller en del heraf, samt middel til brug ved fremgangsmaaden

Country Status (18)

Country Link
US (2) US5077195A (da)
EP (2) EP0332225B1 (da)
JP (1) JPH07215999A (da)
KR (1) KR920002315B1 (da)
AT (2) ATE88572T1 (da)
AU (1) AU592781B2 (da)
BR (1) BR8606615A (da)
CA (1) CA1339606C (da)
DE (2) DE3679017D1 (da)
DK (1) DK521386A (da)
ES (3) ES8705919A1 (da)
FI (1) FI90255C (da)
GR (1) GR860576B (da)
IE (1) IE58837B1 (da)
IL (1) IL96043A0 (da)
NO (1) NO174971C (da)
PT (1) PT82132B (da)
WO (1) WO1986005208A1 (da)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0779717B2 (ja) * 1984-10-29 1995-08-30 マイクロジエニツクス コ−ポレ−シヨン タンパク質結合酵素相補性検定に関する方法
DE3527568A1 (de) * 1985-08-01 1987-02-05 Bissendorf Peptide Gmbh Synthetische peptidrezeptoren, verfahren zur herstellung und verwendung derselben
CA1297003C (en) * 1985-09-20 1992-03-10 Jack H. Nunberg Composition and method for treating animals
WO1987005029A2 (en) * 1986-02-19 1987-08-27 Triton Biosciences Inc Peptides affecting blood pressure regulation
US4772684A (en) * 1987-01-20 1988-09-20 Triton Biosciences, Inc. Peptides affecting blood pressure regulation
DK105289A (da) * 1988-03-04 1989-09-05 Univ Alabama Peptidaekvivalenter til ikke-peptider og fremgangsmaader til udformning af disse
DE69033395D1 (de) * 1989-07-31 2000-01-20 Tecnogen Scpa Verfahren zur Identifizierung und Herstellung von Bindungsstellen aufeinanderwirkender Proteine
US5324512A (en) * 1990-12-26 1994-06-28 The Population Council [Gln']-luteinizing hormone releasing hormone conjugate of tetanus vaccine and its uses
JPH05262788A (ja) * 1991-09-03 1993-10-12 Hitachi Chem Co Ltd ペプチド類、その設計方法及び製造方法並びに受容体上の生理活性ペプチドの結合部位の決定方法
US6017512A (en) * 1992-06-23 2000-01-25 Diatide, Inc. Radiolabeled peptides
US5620675A (en) * 1992-06-23 1997-04-15 Diatech, Inc. Radioactive peptides
RU2145976C1 (ru) * 1993-10-04 2000-02-27 Сумитомо Кемикал Компани, Лимитед Способ получения полипептида (варианты)
WO1995009643A1 (en) * 1993-10-07 1995-04-13 Kurashiki Boseki Kk Endothelin activity inhibitor
US6051206A (en) * 1994-06-03 2000-04-18 Diatide, Inc Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses
IL115177A0 (en) * 1994-09-16 1995-12-31 Immunomedics Inc Phosphorus-32 labeling of antibodies for cancer therapy
US5523208A (en) * 1994-11-30 1996-06-04 The Board Of Trustees Of The University Of Kentucky Method to discover genetic coding regions for complementary interacting proteins by scanning DNA sequence data banks
WO1997001755A2 (en) * 1995-06-26 1997-01-16 Perseptive Biosystems, Inc. High speed, automated, continuous flow, multi-dimensional molecular selection and analysis
US5807552A (en) * 1995-08-04 1998-09-15 Board Of Regents, The University Of Texas System Compositions for conferring immunogenicity to a substance and uses thereof
WO1999027964A1 (en) * 1997-12-01 1999-06-10 Cfy Biomedicals, Inc. Multivalent recombinant antibodies for treating hrv infections
DE19805334A1 (de) * 1998-02-11 1999-08-12 Otogene Biotechnologische Fors Verfahren zur Entwicklung eines pharmazeutischen Wirkstoffes
AU762711C (en) * 1998-04-24 2004-05-27 Fang Fang Identifying peptide ligands of target proteins with target complementary library technology (TCLT)
US20030035798A1 (en) * 2000-08-16 2003-02-20 Fang Fang Humanized antibodies
WO2000053621A2 (en) * 1999-03-09 2000-09-14 Jeffrey Lynn Haddox Synthetic complementary peptides and ophthalmologic uses thereof
GB2356401A (en) * 1999-11-19 2001-05-23 Proteom Ltd Method for manipulating protein or DNA sequence data
GB9929466D0 (en) * 1999-12-13 2000-02-09 Proteom Ltd Complementary peptide ligands generated from microbial genome sequences
GB9929464D0 (en) * 1999-12-13 2000-02-09 Proteom Ltd Complementary peptide ligande generated from the human genome
GB9929469D0 (en) * 1999-12-13 2000-02-09 Proteom Ltd Complementary peptide ligands generated from plant genomes
WO2002027313A1 (en) * 2000-09-26 2002-04-04 Geneformatics, Inc. Methods for determining aproximations of three dimensional polypeptide structure
GB0025251D0 (en) * 2000-10-14 2000-11-29 Proteom Ltd Antisense peptides to Fc receptors and their uses
AU2002253981B2 (en) * 2001-02-20 2008-02-21 Abeome Corporation Rapid production of monoclonal antibodies
CA2454358A1 (en) 2001-07-19 2003-07-31 Perlan Therapeutics, Inc. Multimeric proteins and methods of making and using same
RU2422458C2 (ru) * 2006-03-23 2011-06-27 Кьюравак, Инк. Комплементарный пептид к основному иммуногенному району рецептора ацетилхолина, терапевтическая композиция на его основе, способ изготовления пептида и его применение
US8227583B2 (en) 2007-06-14 2012-07-24 The Board Of Regents For Oklahoma State University Vaccines containing canine parvovirus genetic variants
CN106048082A (zh) * 2007-06-14 2016-10-26 俄克拉荷马州大学评议会 包含犬细小病毒遗传性变体的疫苗
US20190062373A1 (en) * 2017-08-30 2019-02-28 Peption, LLC Method of generating interacting peptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) * 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes

Also Published As

Publication number Publication date
PT82132B (pt) 1989-05-31
JPH07215999A (ja) 1995-08-15
ES8800266A1 (es) 1987-11-01
NO864369L (no) 1987-01-02
NO174971B (no) 1994-05-02
EP0214232A1 (en) 1987-03-18
CA1339606C (en) 1997-12-30
FI90255C (fi) 1994-01-10
BR8606615A (pt) 1987-08-11
ES557188A0 (es) 1987-11-01
DE3688333T2 (de) 1993-10-28
EP0332225A3 (en) 1989-09-27
IL96043A0 (en) 1991-07-18
KR920002315B1 (ko) 1992-03-21
KR870700100A (ko) 1987-02-28
ATE88572T1 (de) 1993-05-15
DE3679017D1 (de) 1991-06-06
IE860527L (en) 1986-09-01
ES8800267A1 (es) 1987-11-01
DK521386D0 (da) 1986-10-31
EP0332225A2 (en) 1989-09-13
PT82132A (en) 1986-04-01
US5077195A (en) 1991-12-31
ES557189A0 (es) 1987-11-01
AU5510286A (en) 1986-09-24
ES8705919A1 (es) 1987-05-16
IE58837B1 (en) 1993-11-17
FI90255B (fi) 1993-09-30
ATE63138T1 (de) 1991-05-15
US5212072A (en) 1993-05-18
DE3688333D1 (de) 1993-05-27
EP0332225B1 (en) 1993-04-21
WO1986005208A1 (en) 1986-09-12
FI864427A7 (fi) 1986-10-30
AU592781B2 (en) 1990-01-25
NO864369D0 (no) 1986-10-31
NO174971C (no) 1994-08-10
GR860576B (en) 1986-07-01
FI864427A0 (fi) 1986-10-30
EP0214232B1 (en) 1991-05-02
ES552534A0 (es) 1987-05-16

Similar Documents

Publication Publication Date Title
DK521386A (da) Fremgangsmaade til bestemmelse af aminosyre-sekvensen af et polypeptid, som er komplementaert til et peptid eller protein eller en del heraf, samt middel til brug ved fremgangsmaaden
ATE105867T1 (de) Immunaffinitäts-reinigungssystem.
DE3587814D1 (de) Verfahren zum erhalten von dns, rns, peptiden, polypeptiden oder proteinen durch dns-rekombinant-verfahren.
DE3856560D1 (de) Dem menschlichen gewebefaktor ähnliche dns-segmente, polypeptide und antikörper
Benjamini et al. Immunochemical studies on the tobacco mosaic virus protein. I. The immunological relationship of the tryptic peptides of tobacco mosaic virus protein to the whole protein
NO964650L (no) LAG-3 proteinopploselige polypeptidfraksjoner, fremgangsmate for fremstilling, terapeutisk preparat og anti-idiotype antistoff
DK532284A (da) Fremgangsmaade til bestemmelse af antigenaktive aminosyresekvenser
PL393286A1 (pl) Rozpuszczalny receptor BR43x2 i sposoby jego zastosowania
NO975435L (no) Modifiserte/kimeriske proteiner samt anvendelse derav
DK175843B1 (da) Polypeptider af overfladeaktive alvelolarproteiner (ASP), farmaceutisk sammensætning indeholdende polypeptidet, DNA-ekspressionssystem der koder for polypeptidet, samt fremgangsmåde til fremstilling af polypeptider med ASP-aktivitet
DK165506C (da) Proteinpraeparat med koagulationsaktivitet samt fremgangsmaade til fremstilling deraf
DE69227041D1 (de) Expression und reinigung von rekombinantem, löslichem gewebefaktor
BR8605053A (pt) Processos para a preparacao de um polipeptidio,para a preparacao de um gene sintetico,para a preparacao de um vetor de expressao,para a preparacao de um transformante bacteriano,para a determinacao de anticorpos e de virus,para a preparacao de vacina,vacinas,anticorpos,polipeptidos,gene,vetor,transformante,kit de teste
NO891711D0 (no) Hiv env-kodet peptid som er istand til aa fremkalle hiv-inhiberende antistoffer i pattedyr.
DK156592A (da) Human-h1-praeprorelaxin, -prorelaxin og -relaxin samt polypeptid med relaxinaktivitet og fremgangsmaade til sammenfoejning af a- og b-kaederne i human-h1-relaxin
ES539382A0 (es) Procedimiento para la determinacion de fibrina
ES2080060T3 (es) Proteinas que tienen actividad de union a interferon-gamma.
NO900758D0 (no) Fremgangsmaate for fremstilling av hybridprotein.
FI943218A7 (fi) Kaseinomakropeptidin peptidit, mainittujen peptidien vasta-aineet ja k äytöt
NO871737D0 (no) Rekombinant virus, polypeptid samt dna molekyl med kodingssekvens for dette polypeptid.
BR1100801A (pt) Proteìna, peptìdeo, proteìna ou peptìdeo, sequência de dna, processo para a preparação de uma proteìna ou peptìdeo, anticorpo, composição farmacêutica, e, uso de uma proteìna ou peptìdeo

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment